logo

Label-free Array Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Global Label-free Array Systems Market is Segmented by Technology (Surface Plasmon Resonance, Bio-layer Interferometry, Cellular Dielectric Spectroscopy, and Other Technologies), Application, End User, and Geography.

Home Industry Reports Healthcare Label-free Array Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts ...

Market Snapshot

label free array systems market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global label-free array systems market is anticipated to witness steady growth of approximately 6.2% CAGR during the forecast period. In recent years, label-free array systems have taken center stage as the research tool in many drug discovery processes. Label-free technologies are also used by manufacturers in context to patient samples, to produce biorelevant data that can result in effective drug development and precision medicine.

Modern medicine is moving toward precision or personalized medicine, to eliminate dosing redundancy in individuals. However, the biggest challenges in drug discovery and development are individual variability in drug effectiveness and a lack of translatability of pre-clinical results. Hence, companies are focusing on developing appropriate cellular models and readout systems to understand mechanisms and functional characterization on molecular and cellular levels. Moreover, next-gen label-free technologies, including mass spectrometers, biochips/microarrays, and others, have shown positive results in identifying clinical microorganisms. Companies are also developing micro plate-based optical biosensors that can be incorporated in the standard format microplates, to detect small molecules, cells, and proteins.

Scope of the Report

Biotechnology and pharmaceutical companies use label-free array systems in the drug discovery process. It works on the principle of refractive index, impedance-based assays, and optical interferometry, for identifying and validating new molecules as the possible drug candidates. The systems reduce the cost and time for drug identification and validation process. As per the scope of this report, the global label-free array systems market is segmented by technology, application, end user, and geography.

Technology
Surface Plasmon Resonance
Bio Layer Interferometry
Cellular Dielectric Spectroscopy
Other Technologies
Application
Drug Discovery
Protein Interface Analysis
Antibody Characterization and Development
Protein Complex and Cascade Analysis
Other Applications
End User
Contract Research Organizations
Agricultural Research Institutes
R&D Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Surface Plasmon Resonance Technology Segment is Expected to the Exhibit the Fastest Growth During the Forecast Period

Based on the technology, the segmentation includes cellular dielectric spectroscopy, bio-layer interferometry, surface plasmon resonance, and other technologies. Among these, surface plasmon resonance technology is likely to experience a significant growth in the global label-free array systems market. The main contributors can be increasing spending over R&D activities by pharmaceutical and biopharmaceutical companies. According to the report of European Federation of Pharmaceutical Companies, in 2017, the R&D expenditure for European pharmaceutical industry was accounted to be around USD 38,404. Hence, it is expected to influence the market positively.

Label-free Array Systems Market.png

North America Accounted for the Largest Share in the Global Market and is also the Fastest-growing Market

Region-wise, North America is expected to emerge as the leading region in the global label-free array systems market. The rise in chronic and life-threatening diseases is resulting in an increase in drug discovery programs in the United States. This is leading to the increasing demand for label-free array systems in the region. The companies are also introducing label-free cell-based systems for early drug discovery. Meanwhile, certain issues, including a limit of detection and probability of the device, and  the sensitivity of the device, are being optimized by manufacturers to offer better label-free array systems.

Label-free Array Systems Market -Growth Rate by Region

Competitive Landscape

The global label-free array systems market is dominated by a few major players, and the global label-free array systems market is expected to experience growth, owing to the rising collaboration and partnerships between pharmaceutical and biotechnology companies, for expediting various drug discovery/designing processes.

Label-free Array SYstems Market Concentration.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Advantages over Labeled Detection Techniques

      2. 4.2.2 Increase in the R&D Expenditure of Pharmaceutical and Biotechnology Companies

      3. 4.2.3 Technological Advancements in Label-free Technologies

    3. 4.3 Market Restraints

      1. 4.3.1 High Instrumentation Costs

      2. 4.3.2 Lack of Awareness

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Technology

      1. 5.1.1 Surface Plasmon Resonance

      2. 5.1.2 Bio Layer Interferometry

      3. 5.1.3 Cellular Dielectric Spectroscopy

      4. 5.1.4 Other Technologies

    2. 5.2 Application

      1. 5.2.1 Drug Discovery

      2. 5.2.2 Protein Interface Analysis

      3. 5.2.3 Antibody Characterization and Development

      4. 5.2.4 Protein Complex and Cascade Analysis

      5. 5.2.5 Other Applications

    3. 5.3 End User

      1. 5.3.1 Contract Research Organizations

      2. 5.3.2 Agricultural Research Institutes

      3. 5.3.3 R&D Laboratories

      4. 5.3.4 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East & Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Corning Incorporated

      2. 6.1.2 GE Healthcare

      3. 6.1.3 Bruker Corporation

      4. 6.1.4 Bio-rad Laboratories

      5. 6.1.5 Eppendorf AG

      6. 6.1.6 Fluiditic Analytics

      7. 6.1.7 ThermoFisher Scientific

      8. 6.1.8 Shimadzu Corporation

      9. 6.1.9 Danaher Corporation (Molecular Devices LLC - FORTEBIO)

      10. 6.1.10 PerkinElmer

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Development

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Label-free Array Systems Market market is studied from 2018 - 2026.

The Label-free Array Systems Market is growing at a CAGR of 6.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Corning Incorporated, Danaher Corporation, ThermoFisher Scientific, GE Healthcare, Perkin Elmer Inc. are the major companies operating in Label-free Array Systems Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!